Cargando…

Respiratory and Intestinal Microbiota in Pediatric Lung Diseases—Current Evidence of the Gut–Lung Axis

The intestinal microbiota is known to influence local immune homeostasis in the gut and to shape the developing immune system towards elimination of pathogens and tolerance towards self-antigens. Even though the lung was considered sterile for a long time, recent evidence using next-generation seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stricker, Sebastian, Hain, Torsten, Chao, Cho-Ming, Rudloff, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224356/ https://www.ncbi.nlm.nih.gov/pubmed/35743234 http://dx.doi.org/10.3390/ijms23126791

Ejemplares similares

Gut–Lung Axis: Microbial Crosstalk in Pediatric Respiratory Tract Infections
por: Zhu, Wenxia, et al.
Publicado: (2021)

Microbiota Modulation of the Gut-Lung Axis in COVID-19
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

The History of the Intestinal Microbiota and the Gut-Brain Axis
por: Lewandowska-Pietruszka, Zuzanna, et al.
Publicado: (2022)

The gut-lung axis in influenza A: the role of gut microbiota in immune balance
por: Ou, Guosen, et al.
Publicado: (2023)

Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease—In Vitro Studies in Intestinal Cells and Duodenal Biopsies
por: Stricker, Sebastian, et al.
Publicado: (2023)

Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis
por: Wedgwood, Stephen, et al.
Publicado: (2020)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Plant-Based Dietary Fibers and Polysaccharides as Modulators of Gut Microbiota in Intestinal and Lung Inflammation: Current State and Challenges
por: Shen, Yu, et al.
Publicado: (2023)

The microbiome landscape in pediatric Crohn’s disease and therapeutic implications
por: Fetter, Karin, et al.
Publicado: (2023)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

Peptidoglycan Recognition Protein 4 Limits Bacterial Clearance and Inflammation in Lungs by Control of the Gut Microbiota
por: Dabrowski, Alexander N., et al.
Publicado: (2019)

From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis
por: Ahmadi Badi, Sara, et al.
Publicado: (2021)

The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
por: Sencio, Valentin, et al.
Publicado: (2021)

Gut-Lung Axis in COVID-19
por: Allali, Imane, et al.
Publicado: (2021)

The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021)

Editorial: Gut-lung interaction axis
por: Pi, Jiang, et al.
Publicado: (2023)

Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
por: Groves, Helen T., et al.
Publicado: (2018)

Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection
por: Yagi, Kazuma, et al.
Publicado: (2022)

Role of lung and gut microbiota on lung cancer pathogenesis
por: Zhao, Yue, et al.
Publicado: (2021)

Bypassing the Gut–Lung Axis via Microbial Metabolites: Implications for Chronic Respiratory Diseases
por: Bulanda, Edyta, et al.
Publicado: (2022)

Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
por: Bingula, Rea, et al.
Publicado: (2017)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2023)

COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics
por: Qu, Ling, et al.
Publicado: (2022)

Gut Microbiota-brain Axis
por: Wang, Hong-Xing, et al.
Publicado: (2016)

The microbiota-gut- hippocampus axis
por: Salami, Mahmoud, et al.
Publicado: (2022)

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
por: Xu, Lei, et al.
Publicado: (2022)

Diet, Microbiota and Gut-Lung Connection
por: Anand, Swadha, et al.
Publicado: (2018)

Editorial: Role of lung and gut microbiota in the immune response against respiratory viral infections
por: de Souza, Ana Paula Duarte, et al.
Publicado: (2023)

Oral–Gut Microbiota and Arthritis: Is There an Evidence-Based Axis?
por: Lorenzo, Drago, et al.
Publicado: (2019)

The Role of the Microbiome in Asthma: The Gut–Lung Axis
por: Frati, Franco, et al.
Publicado: (2018)

Gut-lung axis and dysbiosis in COVID-19
por: AKTAS, Busra, et al.
Publicado: (2020)

Coronavirus disease 2019 and the gut–lung axis
por: Zhou, Dan, et al.
Publicado: (2021)

Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis
por: Narayana, Jayanth Kumar, et al.
Publicado: (2022)

The gut-lung axis in the CFTR modulator era
por: Lussac-Sorton, Florian, et al.
Publicado: (2023)

Diet and the gut-lung axis in cystic fibrosis – direct & indirect links
por: McKay, Isabelle, et al.
Publicado: (2022)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
por: Chen, Minjia, et al.
Publicado: (2022)

The Role of Respiratory Microbiota in Lung Cancer
por: Wang, Dan, et al.
Publicado: (2021)

The Gut Microbiota and Respiratory Diseases: New Evidence
por: Chunxi, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3rc9jiko9ahev6vfi0o68lsr70